Omri Amirav-Drory is a General Partner at NFX where he invests in Pre-Seed, Seed, and Series A startups across Biotechnology, Tech-Bio, Therapeutics, Diagnostics, Food-Ag, Chemicals, Materials, Energy, Financial Services, and Information Technology. He invests in companies in the United States and Israel, including the San Francisco Bay Area. NFX recently raised $450 million. He serves on the boards of ImmuneBridge, Powerhouse Biology, Permanence Bio, Radar Therapeutics, and TwoStep Therapeutics, and has invested in companies like Mammoth Biosciences, Centivax, Pepper Bio, Mana.bio, and C2i Genomics. Before NFX, he was Founder & chairman of the board at Renewal Bio. Omri studied at Stanford University and Tel Aviv University, and lives in Menlo Park, California.
Omri Amirav-Drory, General Partner @ NFX. Profile with intro opportunities and ranking information.